Intra Cellular Therapies | Операционный Доход


Operating Profit Изменить
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
ALKERMES ALKS:US -34457000 7.87M
Biocryst Pharmaceuticals BCRX:US $ -34.72M 15.24M
Biogen BIIB:US $ -59.1M 669.8M
Bristol Myers Squibb BMY:US $ 2590M 37M
Cytokinetics CYTK:US $ -10.87M 69.68M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Gilead Sciences GILD:US $ 2029M 1832M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Intra Cellular Therapies ITCI:US $ -87.92M 15.26M
JAZZ PHA JAZZ:US $ 85.55M 2M
Johnson & Johnson JNJ:US $ 5840M 22M
Marinus Pharmaceuticals MRNS:US $ -36.77M 20.06M
Minerva Neurosciences NERV:US $ -6.96M 1.02M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Novartis NVS:US $ 2228M 624M
Prothena PRTA:US -43209000 5.26M
Redhill Biopharma RDHL:US $ -13.24M 7.46M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
United Therapeutics UTHR:US $ 201.8M 84.5M
Vanda Pharmaceuticals VNDA:US $ 3.46M 11.13M



Intra Cellular Therapies Операционный Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Aug 2022.